Olio redefines how population health and utilization teams work with post-acute providers. Our software increases the volume and scale of engagement between payers, health systems, and physician groups in partnership with the entirety of their post-acute footprint. Olio provides all users with workflow and collaboration tools needed to drive outcomes and operational efficiencies for patients transitioning through various sites of care.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/29/22 | $13,000,000 | Series A |
Fulcrum Equity Partners Mutual Capital Partners | undisclosed |
